What Is BioLean3 Reta GGG? A Triple-Agonist Explained
Plain answers on BioLean3 Reta GGG: what triple agonist means, which receptor pathways researchers study, what the 30mg vial holds and how it is tested.
Plain answers on BioLean3 Reta GGG: what triple agonist means, which receptor pathways researchers study, what the 30mg vial holds and how it is tested.
Tesamorelin is a long, modified peptide, so a single purity number tells you little. Here is what the mass, HPLC and content results on a 6mg vial’s COA should show.
A plain profile of Selank 5mg: the seven-amino-acid peptide, its link to tuftsin, what the vial contains, how unopened vials are stored and how it is tested.
A plain-English look at what published laboratory research has examined about LL-37, the cathelicidin peptide, how strong that evidence is, and what remains unknown.
A plain profile of the BioPure DSIP 5mg vial: what the peptide is, what ships in the vial, what published research has examined, and how it is tested and stored.
TA1 Complex pairs thymosin alpha-1 with thymalin in one vial. Here is how it differs from single-compound thymosin alpha-1 in structure, research focus and what a COA should show.
A plain-language overview of what published laboratory research has examined about VIP, its VPAC receptors, and how strong the evidence is.
Epithalon and DSIP are both short peptides studied in circadian and neuroendocrine research. Here is how their size, targets, evidence and COA identity checks differ.
TA1, Tα1 and thymosin alpha usually point to one 28-amino-acid peptide, but similar names refer to different molecules. Here is how to tell them apart and what to check on a label.
A plain-language look at the GLP-1 research history behind BioLean1 Sema: the gut hormone, the gene it came from, and why researchers built analogs.